Below are the financial statements of Zealand Pharma, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.
| All figures in millions of DKK | 2024 | 2023 |
|---|---|---|
| Revenue | 62.69a | 342.79a |
| Royalty expenses | 0a | -9.14a |
| Cost of goods sold | -7.87a | -10.04a |
| Gross profit | 54.82a | 323.61a |
| Research and development expenses | -919.87a | -684.9a |
| Sales and marketing expenses | -88.12a | -30.63a |
| General and administrative expenses | -315.91a | -185.3a |
| Other operating income | 0a | 15.98a |
| Other operating expenses | -3.14a | -11a |
| Net operating expenses | -1,327.02a | -895.85a |
| Operating result | -1,272.21a | -572.24a |
| Financial income | 240.26a | 54.12a |
| Financial expenses | -51.5a | -190.74a |
| Result before tax | -1,083.45a | -708.87a |
| Corporate tax | -4.62a | -5.13a |
| Net result for the year | -1,078.83a | -703.74a |
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Zealand Pharma’s data sources below and access millions more through our Disclosure Search.